The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC
2021 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-021-89006-9
Y
Yoshihiko Taniguchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
163
Papers
1.9K
Citations
24
h-index
54
i10-index
Yoshihiko Taniguchi is an academic researcher from NHO Kinki Chuo Chest Medical Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 24, co-authored 139 publications.
ORCID: 0000-0001-6387-3683Papers by this author
worksIdentification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning
2025 · Lung Cancer · 4 citations
https://doi.org/10.1016/j.lungcan.2024.108079
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
2024 · BMC Pulmonary Medicine · 1 citations
https://doi.org/10.1186/s12890-024-03212-5
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA
2025 · Investigational New Drugs · 0 citations
https://doi.org/10.1007/s10637-024-01500-9
Case of a rare EGFR mutation L747P identified using the lung cancer compact Panel™ leading to successful Afatinib treatment
2025 · Respiratory Medicine Case Reports · 0 citations
https://doi.org/10.1016/j.rmcr.2025.102255
Distal femoral central venous catheterization in a semi-sitting position for a patient with lung cancer and superior vena cava syndrome: A case report
2026 · Current Problems in Cancer Case Reports · 0 citations
https://doi.org/10.1016/j.cpccr.2026.100410
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat